8th Edition of World Congress on Infectious Diseases
June 09-11, 2025 | Rome, Italy
Viruses and Cancer
A virus is a parasitic organism that cannot replicate on its own. A virus, on the other hand, can command the cell machinery to make new viruses once it has infected a susceptible cell. The genetic substance of most viruses is either RNA or DNA. Single-stranded or double-stranded nucleic acids are both possible. The nucleic acid and a protein outer shell make up the entire infectious virus particle, known as a virion. Only enough RNA or DNA is present in the smallest viruses to encode four proteins. The most complicated genes can encode between 100 and 200 proteins. Infectious pathogens are responsible for around a fifth of all human malignancies globally. Seven distinct viruses have been causally related to human oncogenesis in 12% of cancers.
- Oncolytic Viruses
- Oncogenic Viruses and Cancer
- Cancer Immunotherapy
Francis J. Castellino
University of Notre Dame, United States
Stephen Hsu
Augusta University, United States
Ronald Desrosiers
University of Miami Miller School of Medicine, United States
Dong H Kwon
Long Island University, United States
Debra Hawkins
University of Oklahoma, United States
Pedro Plans Rubio
College of Physicians of Barcelona, Spain
Antonella Cardone
Cancer Patients Europe, BelgiumSubmit your abstract Today
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global climate change and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Impressive virologic suppression of SHIV infection with long-term AAV delivery of monoclonal antibodies
Ronald Desrosiers, University of Miami Miller School of Medicine, United States
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States